Cell therapy weekly: US FDA approves IND application for Zofin™ in the treatment of COPD

This week: the US FDA has approved an Investigational New Drug application for Zofin™ in the treatment of patients with chronic obstructive pulmonary disease, researchers have successfully ‘fine-tuned’ a new thermoplastic biomaterial for soft tissue engineering, and Thermo Fisher Scientific has launched the first specific T-cell medium for allogeneic cell therapy workflows. The news highlights: US FDA approves IND application for Zofin™ in the treatment of COPD New biomaterials successfully ‘fine-tuned’ for soft tissue engineering Thermo Fisher Scientific launches first T-cell medium for allogeneic cell therapy workflows   US FDA approves IND application for Zofin™ in the treatment of COPD...